Reform of the patent process in the United States is shaping up as a battle of wills between the software and biotechnology industries. The outcome has global consequences, as Emma Marris reports.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Related links
Related links
Related links in Nature Research
Surge in US patents on botanicals
Integra v. Merck: A mixed bag for research tool patents
Related external links
Federal Trade Commission (FTC) patent reform report
American Intellectual Property Law Association response to FTC report
National Academies Press (NAS) patent reform report
American Intellectual Property Law Association response to NAS report
United States Patent and Trademark Office (USTPO) Strategic Plan
Rights and permissions
About this article
Cite this article
Patent reform prompts intellectual tug-of-war. Nature 437, 1230–1231 (2005). https://doi.org/10.1038/4371230a
Published:
Issue Date:
DOI: https://doi.org/10.1038/4371230a
This article is cited by
-
Patent examiners call in the jury
Nature (2007)
